Zinc supplementation decreased incidence of grade≥2 hand-foot skin reaction induced by regorafenib: a phase II clinical trial
Published: 24 April 2023| Version 1 | DOI: 10.17632/dw2cwjsc8d.1
Contributor:
Wen-Kuan HuangDescription
Supplemental figure 1.
Files
Institutions
Chang Gung Memorial Hospital Linkou Branch
Categories
Zinc, Tyrosine Kinase Inhibitor, Dermal Toxicity
Funding
Chang Gung Medical Foundation